Cosmos Health's Cosmofarm Expands Customer Base, Boosts Unit Economics with $40M Revenue Target
Event summary
- Cosmofarm added nearly 100 new pharmacy customers in 2025, a 20% weighted average increase in its active customer base.
- Annual revenue per customer increased by 12%, and profitability per customer improved by 14% due to enhanced route density and operational leverage.
- Cosmofarm introduced three new delivery routes in the Attica region to strengthen service quality and last-mile delivery performance.
- A $1 million capital investment program is underway to expand robotic capacity and throughput, supporting incremental annual revenue potential of $40 million.
The big picture
Cosmos Health's focus on automation and operational efficiency at Cosmofarm aligns with broader industry trends toward digitization and last-mile optimization in pharmaceutical distribution. The company's strategic investments in robotic systems and infrastructure underscore its commitment to scaling its distribution capabilities, positioning it to capture a larger share of Greece's densely populated pharmaceutical markets. The integration of advanced technologies like ROWA and A-frame robotic systems highlights the growing importance of automation in enhancing service quality and delivery performance.
What we're watching
- Customer Growth
- Whether Cosmofarm can sustain the 20% customer growth rate in 2026 as management expects.
- Automation Impact
- How the expanded robotic capacity will affect processing speed, accuracy, and overall operational efficiency.
- Revenue Potential
- The pace at which Cosmofarm can realize the $40 million incremental annual revenue potential through expanded distribution capability.
Related topics